Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback